Skip to content

Clinical trials

Phase 4 Hypertension trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: South Korea Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20051
20063
20077
20082
20095
20105
20111
20125
20131
20144
20154
20162
20173
20184
20194
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Unknown status6
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical6
Yonsei University6
Asan Medical Center5
Boehringer Ingelheim4
AstraZeneca3
Boryung Pharmaceutical Co., Ltd3
Seoul National University Bundang Hospital3
Yuhan Corporation3
Bayer2
Gachon University Gil Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension59
Dyslipidemias5
Diabetes Mellitus, Type 24
Diabetic Nephropathies3
Essential Hypertension2
Heart Failure2
Hypercholesterolemia2
Hypertrophy, Left Ventricular2
Insulin Resistance2
Albuminuria1

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.